Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.

Matteo AllegrettiAlessandra FabiElena GiordaniCristiana ErcolaniPaolo RomaniaCecilia NisticòSimona GasparroVittoria BarberiMaria CiolinaEdoardo PescarmonaDiana GiannarelliGennaro CilibertoFrancesco CognettiPatrizio Giacomini

Published in: Molecular cancer (2021)

Keyphrases

positive breast cancer
epidermal growth factor receptor
genome wide
ultrasound guided
metastatic breast cancer
fine needle aspiration
ionic liquid
glycemic control
metabolic syndrome
gene expression
adipose tissue